Related Experiment Video
Updated: Jul 4, 2025

Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017
Mac-1 deficiency ameliorates pressure overloaded heart failure through inhibiting macrophage polarization and
Qiu-Yue Lin1, Wei-Jia Yu1, Jie Bai2
1Institute of Cardiovascular Diseases, First Affiliated Hospital of Dalian Medical University, Dalian, China.
Insights
Macrophage-1 antigen (Mac-1) deficiency ameliorates cardiac remodeling and dysfunction following pressure overload. Mac-1 knockout mice showed reduced heart failure, suggesting Mac-1 inhibition as a potential therapeutic strategy.
Area of Science:
- Cardiovascular Biology
- Immunology
- Pathology
Background:
- Persistent pressure overload causes pathological cardiac hypertrophy, remodeling, and heart failure (HF).
- Immune cell involvement and inflammation are key in cardiac remodeling pathogenesis.
- Macrophage-1 antigen (Mac-1) regulates leukocyte migration and polarization, but its role in pressure overload-induced cardiac remodeling is unknown.
Purpose of the Study:
- To investigate the role of Mac-1 in cardiac remodeling and heart failure induced by pressure overload.
- To determine the effects of Mac-1 deficiency on cardiac function and pathology in response to transverse aortic constriction (TAC).
Main Methods:
- Macrophage-1 antigen-knockout (KO) and wild-type (WT) mice underwent TAC for 6 weeks.
- Cardiac function was assessed using echocardiography and pressure-volume loop analysis.
- Cardiac remodeling, macrophage infiltration, and polarization were evaluated via histopathology and molecular techniques.
Main Results:
- Mac-1 expression increased significantly in TAC-treated hearts.
- Mac-1-KO mice exhibited significantly improved cardiac function and reduced hypertrophy, fibrosis, oxidative stress, and apoptosis compared to WT mice.
- Mac-1 deficiency inhibited macrophage infiltration and M1 polarization, associated with altered NF-kB, STAT1, and STAT6 expression.
Conclusions:
- Mac-1 deficiency confers protection against pathological cardiac remodeling and heart failure induced by pressure overload.
- Inhibiting Mac-1 presents a potential therapeutic avenue for treating heart failure.
Abstract:
Persistent pressure overload commonly leads to pathological cardiac hypertrophy and remodeling, ultimately leading to heart failure (HF). Cardiac remodeling is associated with the involvement of immune cells and the inflammatory response in pathogenesis. The macrophage-1 antigen (Mac-1) is specifically expressed on leukocytes and regulates their migration and polarization. Nonetheless, the involvement of Mac-1 in cardiac remodeling and HF caused by pressure overload has not been determined. The Mac-1-knockout (KO) and wild-type (WT) mice were subjected to transverse aortic constriction (TAC) for 6 weeks. Echocardiography and pressure-volume loop assessments were used to evaluate cardiac function, and cardiac remodeling and macrophage infiltration and polarization were estimated by histopathology and molecular techniques. The findings of our study demonstrated that Mac-1 expression was markedly increased in hearts subjected to TAC treatment. Moreover, compared with WT mice, Mac-1-KO mice exhibited dramatically ameliorated TAC-induced cardiac dysfunction, hypertrophy, fibrosis, oxidative stress and apoptosis. The potential positive impacts may be linked to the inhibition of macrophage infiltration and M1 polarization via reductions in NF-kB and STAT1 expression and upregulation of STAT6. In conclusion, this research reveals a new function of Mac-1 deficiency in reducing pathological cardiac remodeling and HF caused by pressure overload. Additionally, inhibiting Mac-1 could be a potential treatment option for patients with HF in a clinical setting.
Related Concept Videos
Pathophysiology of Heart Failure
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

